Mark Temper
Impact in
-
- Cancer Genomics and Diagnostics
-
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
Papers in
- Oncology 7
- Cancer Treatment and Pharmacology 3
- Colorectal Cancer Treatments and Studies 3
-
- Cancer Genomics and Diagnostics 5
- Co-authors
- Tamar Peretz (10 shared papers)Ayala Hubert (7 shared papers)Azzam Salah (4 shared papers)Beatrice Uziely (5 shared papers)Esther Tahover (4 shared papers)Ilya Tsimafeyeu (1 shared paper)Tamar Hamburger (3 shared papers)Kıvanç Ateşok (1 shared paper)
- Journals
- Annals of Oncology (2 papers)Annals of Surgical Oncology (1 paper)Nature Biotechnology (1 paper)Journal of Cancer (1 paper)Medicine (1 paper)
- Partner nations
- IsraelUnited StatesJordan
In The Last Decade
Mark Temper
14 papers receiving 183 citations
Peers
Comparison fields: 5 of 50
- Cancer Research 38
- Oncology 54
- Health Informatics 2
- Hepatology 8
- Pulmonary and Respiratory Medicine 29
Countries citing papers authored by Mark Temper
This map shows the geographic impact of Mark Temper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Temper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Temper more than expected).
Fields of papers citing papers by Mark Temper
This network shows the impact of papers produced by Mark Temper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Temper. The network helps show where Mark Temper may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Temper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 61 | |
| 2 | 2012 | 38 | |
| 3 | 2007 | 25 | |
| 4 | 2014 | 18 | |
| 5 | 2021 | 11 | |
| 6 | 2008 | 9 | |
| 7 | 2015 | 8 | |
| 8 | 2020 | 7 | |
| 9 | 2017 | 3 | |
| 10 | 2017 | 2 | |
| 11 | 2015 | 1 | |
| 12 | 2009 | 1 | |
| 13 | 2016 | 1 | |
| 14 | 2012 | 1 | |
| 15 | 2024 | 0 |
About Mark Temper
Mark Temper is a scholar working on Oncology, Cancer Research, Surgery, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 15 papers that have together received 186 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (5 papers), Cancer Treatment and Pharmacology (3 papers), Lung Cancer Treatments and Mutations (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Genetic factors in colorectal cancer (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Cancer Mechanisms and Therapy (1 paper) and Intraperitoneal and Appendiceal Malignancies (1 paper). The work is most often cited by research in Cancer Research (38 citations), Oncology (54 citations), Health Informatics (2 citations), Hepatology (8 citations) and Pulmonary and Respiratory Medicine (29 citations). Mark Temper has collaborated with scholars based in Israel, United States and Jordan. Frequent co-authors include Tamar Peretz, Ayala Hubert, Azzam Salah, Beatrice Uziely, Esther Tahover, Ilya Tsimafeyeu, Tamar Hamburger, Kıvanç Ateşok, Rami Mosheiff and Amos Peyser. Their work appears in journals such as Annals of Oncology, Annals of Surgical Oncology, Nature Biotechnology, Journal of Cancer and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.